Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
2014
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults
2017
Osteoporosis
2019 Standout
Acute kidney injury
2012 Standout
Diabetic retinopathy
2010 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
2002
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
2020
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Cholesterol reduction and its impact on coronary artery disease and total mortality
1995
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
2014
Effect of Statins on Risk of Coronary Disease
1999
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes
2010
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
Diabetes and Atherosclerosis
2002 Standout
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors
2020
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Biomarkers of inflammation predict both vascular and non-vascular mortality in older men
2008
The role of atherosclerosis in osteoarthritis
2017
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
2012
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Atherosclerosis
2019 Standout
Reactive oxygen species in cardiovascular disease
2011
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials
2001
Antioxidant supplements for preventing gastrointestinal cancers
2004
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
2008
Osteoarthritis
2019 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Biomarkers in Heart Failure
2008 Standout
Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies
2014 Standout
Chronic Kidney Disease
2016 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
2016
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2004 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Antioxidant supplements for preventing gastrointestinal cancers
2008
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
2012
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
B Vitamin and/or ω-3 Fatty Acid Supplementation and Cancer
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
2020
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
LPA Gene, Ethnicity, and Cardiovascular Events
2016
Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
2019
Works of Jane Armitage being referenced
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events
2019
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
2016
The safety of statins in clinical practice
2007
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Cardiovascular outcomes among participants with diabetes in the recent large statin trials
2004
Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care
2016
Cholesterol Fractions and Apolipoproteins as Risk Factors for Heart Disease Mortality in Older Men
2007
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
1996
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
2018
N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study
2007
MRC/BHF Heart Protection Study
2002
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study
1994
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
2010
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
2016
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
1995
Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B12vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors
2010
Lipoprotein(a) Genetic Variants Associated With Coronary and Peripheral Vascular Disease but Not With Stroke Risk in the Heart Protection Study
2011
Heart Protection Study
2003